Immunome Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
IMNM on Nasdaq
Industry
Pharmaceutical Preparations
Location
18702 N. Creek Parkway, Suite 100, Bothell, WA

Insiders trading volume in the past year

Immunome Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Isaac Barchas Director $16.7M Jun 13, 2024
Michael Rapp Director $7.56M Oct 2, 2023
Clay B. Siegall President and CEO, Director $5.88M +$4.51M +330% Mar 26, 2025
Max Rosett Chief Financial Officer $760K -$230K -23.2% Sep 19, 2024
John L. Lamattina Director $396K Jun 8, 2023
Franklyn G. Prendergast Director $360K Oct 2, 2023
Philip Tsai Chief Technology Officer $280K +$302K Mar 24, 2025
Bruce Turner Chief Strategy Officer $250K Aug 9, 2024
Jean Jacques Bienaime Director $244K +$243K +16118% Mar 25, 2025
Michael Lefenfeld Director $241K Jun 8, 2023
Robert Lechleider Chief Medical Officer $150K +$150K Nov 21, 2024
Bob Lapetina PAO and VP Finance & Corporate $71.2K Jan 2, 2024
Jack Higgins Chief Scientific Officer $25.3K -$49.1K -66% Mar 27, 2025
Richard A. Baron Director Jun 8, 2023
Sandra M. Swain Director Jun 13, 2024
Phil Noland Roberts Chief Technology Officer Dec 13, 2023
Philip Wagenheim Director Jun 13, 2024
James P. Boylan Director Jun 13, 2024
Carol Schafer Director Jun 13, 2024
Sandra Stoneman Chief Legal Officer & Gc Aug 9, 2024
Purnanand D. Sarma President and CEO, Director Jun 8, 2023
Dennis H. Giesing Chief Development Officer Jun 8, 2023
Corleen Roche Chief Financial Officer Jun 8, 2023
Michael Widlitz Director May 28, 2021
Matthew K. Robinson Chief Technology Officer Jun 8, 2023
Kinney Horn Chief Business Officer Aug 9, 2024

Recent Insider Transactions by Companies or Individuals for Immunome Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.